Scientists have developed a molecular “clock” that could reshape how pediatricians measure and monitor childhood growth and potentially allow for an earlier diagnosis of life-altering development disorders. The research, published this week in PNAS, describes how the addition of chemical tags to DNA over time can potentially be used to screen for developmental differences and health problems in children.
Discovery Talks are the research community's international seminar series. Featuring influential research leaders from around the globe, the series promotes knowledge exchange, fosters international collaborations and showcases the latest innovations in research.
The Brain, Behaviour & Development Theme at BC Children's Hospital presents:
The seminar is scheduled for Thursday, October 3, 2019, 11 a.m. to 12 p.m. at the Chan Centre for Family Health Education, BC Children's Hospital Research Institute (Map). Lunch will follow in the Chieng Family Atrium.
Discovery Talks is accredited as a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada. CME credits are available for all participants.
About the Speaker
Dr. Xavier Castellanos studied Chomskian linguistics at Vassar College, experimental psychology at the University of New Orleans, and medicine at Louisiana State University in Shreveport. He was in the first cohort of “triple board” residents (combined training in pediatrics, psychiatry, and child and adolescent psychiatry) at the University of Kentucky, after which he spent a decade learning from Judy Rapoport at the U.S. National Institute of Mental Health. In 2001, he moved to New York University, where he is an endowed professor of child and adolescent psychiatry, and professor of radiology and neuroscience. His work has focused on using brain imaging to begin to understand the neurobiology of attention-deficit/hyperactivity disorder and autism spectrum disorder. Dr. Castellanos was an early advocate of examining low-frequency fluctuations in brain function and in behavior – both of which have become mainstream lines of investigation. Accordingly, he has been consistently identified among the top 1% of cited scientists in psychiatric neuroscience. He has served on many national and international review committees and was Vice-Chair of the American Psychiatric Association DSM-5 Workgroup on ADHD. His proudest achievements are his extensive network of collaborators and former mentees who are now leaders in the field.
Video recordings of previous lectures are available online. These may be useful for classes, or of interest to those who are unable to attend events.
For more information, contact please firstname.lastname@example.org.